2021-01-11,"Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials"
2021-01-05,Magenta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-17,Is MGTA A Good Stock To Buy Now?
2020-12-07,"Magenta Therapeutics Announces Commencement of First Phase 2 Clinical Trial of MGTA-145 for Stem Cell Mobilization, Oral Presentation of MGTA-145 Phase 1 Results and Update on Targeted ADC Conditioning Program MGTA-117 at ASH Annual Meeting"
2020-12-04,"Zacks.com featured highlights include: Blue Apron Holdings, Magenta Therapeutics, Credit Acceptance Corp, Clean Harbors and LogicBio Therapeutics"
2020-12-04,Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate Magentas MGTA-145 for Mobilizing and Collecting Stem Cells in Adults and Adolescents with Sickle Cell Disease
2020-12-03,Bet on 5 Top Stocks With Rising P/E for Spectacular Returns
2020-11-09,Magenta Therapeutics Appoints Steve Mahoney as Chief Financial and Operating Officer
2020-11-05,Magenta Therapeutics Reports Recent Business Highlights and Third Quarter Financial Results
2020-11-04,Magenta Therapeutics Announces Multiple Presentations Across Stem Cell Transplant Portfolio at The American Society of Hematology (ASH) Annual Meeting
2020-11-02,We're Hopeful That Magenta Therapeutics (NASDAQ:MGTA) Will Use Its Cash Wisely
2020-10-07,"Hedge Funds Have Never Been This Bullish On Magenta Therapeutics, Inc. (MGTA)"
2020-09-29,AVROBIO's Gaucher Disease Candidate Gets Orphan Drug Status
2020-09-11,Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in September
2020-09-02,Magenta Therapeutics Named Co-Recipient of Grant from the National Institutes of Health to Explore Use of Novel Targeted Conditioning Agents with Gene Editing Approaches to Cure HIV
2020-09-02,"Magenta Therapeutics Appoints Lisa M. Olson as Chief Scientific Officer and Kevin B. Johnson as Senior Vice President, Head of Regulatory and Quality; Announces Transition of Jason Ryan, Chief Operating and Financial Officer"
2020-08-31,Magenta Therapeutics Announced It Will Present Clinical and Pre-Clinical Data from Across Immune and Blood System Reset Portfolio at European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting
2020-08-13,Wedbush: 3 Healthcare Stocks Under $10 With Massive Upside Ahead
2020-08-06,Magenta Therapeutics Reports Recent Business Highlights and Second Quarter Financial Results
2020-08-04,"Here's What Magenta Therapeutics, Inc.'s (NASDAQ:MGTA) Shareholder Ownership Structure Looks Like"
2020-08-03,Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August
2020-07-15,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-07-08,"Here is What Hedge Funds Think About Magenta Therapeutics, Inc. (MGTA)"
2020-07-06,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-07-06,Magenta (MGTA) Looks Good: Stock Adds 5.2% in Session
2020-07-05,Big DraftKings Investor Bought Up an Embattled Biotech Stock
2020-06-30,"Magenta Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters Option to Purchase Additional Shares"
2020-06-24,Magenta Therapeutics Announces Pricing of Public Offering
2020-06-24,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-24,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-24,Magenta Therapeutics Launches Proposed Public Offering
2020-06-22,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-20,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-17,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-16,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-15,"MGTA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Magenta Therapeutics, Inc. and Encourages Investors to Contact the Firm"
2020-06-15,Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
2020-06-13,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-12,"MGTA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Magenta Therapeutics, Inc. and Encourages Investors to Contact the Firm"
2020-06-11,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA"
2020-06-11,Magenta Therapeutics Provides Portfolio Update: Stem Cell Mobilization and Conditioning Programs Prioritized and Advancing Toward Clinical Milestones
2020-06-11,Magenta Therapeutics Announces Collaboration with the National Marrow Donor Program/Be The Match to Advance Development of MGTA-145 for First-Line Mobilization of Stem Cells from Healthy Donors and Subsequent Patient Transplant
2020-06-11,"Magenta Therapeutics' Shares March Higher, Can It Continue?"
2020-06-08,Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences
2020-06-05,Magenta Therapeutics Presents Data Supporting Immune Reset for Autoimmune Diseases
2020-05-14,Magenta Therapeutics Presents Data at Annual Meeting of American Society of Gene and Cell Therapy Demonstrating Cells Mobilized with MGTA-145 in a Phase I Trial Are Effective in Gene Therapy Settings
2020-05-07,Magenta Therapeutics Reports Recent Business Highlights and First Quarter Financial Results
2020-05-06,Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
2020-05-06,AVROBIO and Magenta Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
2020-04-30,Magenta Therapeutics to Host Business Update Conference Call
2020-04-28,Magenta Therapeutics to Present Data from Across Portfolio at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
2020-04-17,"Magenta Therapeutics Names John Davis Jr., M.D., M.P.H, M.S., Head of Research and Development"
2020-04-16,Magenta Therapeutics Provides Business Update
2020-04-07,We Think Magenta Therapeutics (NASDAQ:MGTA) Can Afford To Drive Business Growth
2020-03-03,Magenta Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
2020-02-26,"Magenta Therapeutics to Participate in Cowen Health Care Conference on Monday, March 2nd in Boston"
2020-02-24,"Magenta Therapeutics Completes Dosing in Phase 1 MGTA-145 Trial, Demonstrating Rapid, Single-Day First Line Stem Cell Mobilization and Collection"
2020-02-24,Magenta Conditioning Lead Clinical Candidate MGTA-117 Demonstrates Broad Tolerability and High Therapeutic Index in Non-human Primates
2020-02-20,"Magenta Therapeutics Announces Updated Phase 2 Data on MGTA-456 Cell Therapy, Demonstrating Continued Durability in Inherited Metabolic Disorders"
2020-02-16,3 Monster Growth Stocks That Can Charge Forward in 2020
2020-02-06,"Magenta Therapeutics to Participate in Guggenheim Healthcare Talks Oncology Day on Thursday, February 13th in New York City"
2020-02-05,"Magenta Therapeutics Expands Leadership Team, Appoints Kristen Stants as Chief People Officer and Li Malmberg as Senior Vice President, Head of Manufacturing"
2020-01-13,"Magenta Therapeutics Advances Conditioning Platform and Clinical Programs, Highlights Recent Milestones and 2020 Goals"
2020-01-06,"Magenta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15th in San Francisco"
2019-12-19,"Did Hedge Funds Drop The Ball On Magenta Therapeutics, Inc. (MGTA) ?"
2019-12-11,"Goldman Sachs: The Good, the Bad and the Ugly of the Biotech Sector"
2019-12-09,Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug Conjugate
2019-12-07,First Clinical Data with MGTA-145 Show Single-Day Dosing and Collection of Robust Numbers of High-Quality Stem Cells in Healthy Volunteers
2019-12-07,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling"
2019-12-01,"The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More"
2019-11-26,"Magenta Therapeutics to Present at the Evercore ISI HealthCONx Conference on Tuesday, December 3rd"
2019-11-13,Magenta Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
2019-11-11,Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR
2019-11-06,Magenta Therapeutics to Present New Clinical and Preclinical Data at American Society of Hematology (ASH) Annual Meeting
2019-10-30,"Magenta Therapeutics, Inc. (MGTA) Is Burning These Hedge Funds"
2019-10-16,"Magenta Therapeutics Appoints Jan Pinkas as Senior Vice President, Head of Translational Sciences and Announces Transition of Chief Scientific Officer"
2019-10-09,Magenta Therapeutics Sees Hammer Chart Pattern: Time to Buy?
2019-10-08,"Did Magenta Therapeutics, Inc. (NASDAQ:MGTA) Insiders Sell Shares?"
2019-09-04,Magenta Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to MGTA-456 for the Treatment of Inherited Metabolic Disorders
2019-08-08,Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
2019-08-06,"Magenta Therapeutics to Present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 13th"
2019-07-12,CORRECTING and REPLACING Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
2019-06-24,Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
2019-06-22,Can You Imagine How Magenta Therapeutics's (NASDAQ:MGTA) Shareholders Feel About The 12% Share Price Increase?
2019-06-06,"Magenta Therapeutics to Present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11th"
2019-05-09,Magenta Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights
2019-05-09,Magenta Therapeutics Presents Updated Phase 2 Clinical Data on MGTA-456 Cell Therapy at American Academy of Neurology Annual Meeting
2019-05-06,Magenta Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
2019-05-01,Magenta Therapeutics Announces Pricing of Public Offering
2019-04-29,Magenta Therapeutics Launches Proposed Public Offering
2019-04-29,Magenta Therapeutics to Present Preclinical Data on E478 Stem Cell Gene Therapy Expansion Program at the 2019 Annual Meeting of the American Society of Gene and Cell Therapy
2019-04-24,"Magenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate"
2019-04-07,3 Stocks That Have More Than Tripled So Far in 2019
2019-03-20,Raymond James Thinks Magenta Still Has Upside
2019-03-19,Magenta Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights
2019-03-15,"How Many Insiders Bought Magenta Therapeutics, Inc. (NASDAQ:MGTA) Shares?"
2019-03-06,Magenta Therapeutics to Present at Investor Conferences in March
2019-02-25,"Magenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs, Including First Conditioning Development Candidate"
2019-02-25,Magenta Therapeutics Presents Clinical and Preclinical Data on MGTA-456 Cell Therapy in Best Abstracts Sessions at Transplant and Cellular Therapy (TCT) Annual Meeting
2019-02-21,"Magenta Therapeutics Presents Preclinical Data on MGTA-145, First-Line Stem Cell Mobilization Product Candidate for Autologous and Allogeneic Bone Marrow Transplant"
